Skip to content

CapEx at other companies

Pfizer logo
PfizerPFE
$436M-22.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.05B+31.9%
Merck & Co. logo
Merck & Co.MRK
$991M-25.4%
Gilead Sciences logo
Gilead SciencesGILD
$117M+12.5%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$73K+462%
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue$11.5B+2.6%
Gross profit$8.1B-1.2%
Net income$2.7B+9.0%
EPS (diluted)$1.31+9.2%

Balance sheet

See full
Cash & equivalents$9.6B-12.0%
Total debt$44.7B-10.5%
Total equity$20.1B+15.4%
Total assets$86.5B-6.4%

Cash flow

See full
Operating cash flow$1.1B-43.5%
Free cash flow$757.0M-55.3%

Valuation

See full
Market cap$113.11B+18.6%
Enterprise value$148.2B+10.3%
P/E15.6×-2.3×
P/S2.3×+0.3×

Profitability

See full
Gross margin70.5%0.0pp
Net margin15%+3.8pp
FCF margin24.6%-2.9pp

Returns & leverage

See full
Return on equity38.8%+7.3pp
Debt / equity2.2×-0.6×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Bristol-Myers Squibb in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bristol-Myers Squibb's capex?
Bristol-Myers Squibb (BMY) reported capex of $347M in Q1 2026.
How has Bristol-Myers Squibb's capex changed year-over-year?
Bristol-Myers Squibb's capex increased by 33.5% year-over-year, from $260M to $347M.
What is the long-term trend for Bristol-Myers Squibb's capex?
Over 4 years (2021 to 2025), Bristol-Myers Squibb's capex has grown at a 7.7% compound annual growth rate (CAGR), from $973M to $1.31B.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.